沒有 思雋 的照片 楊

查看斯高帕斯 (Scopus) 概要

楊 思雋

Doctor

  • 122 引文
  • 7 h-指數
20112019
如果您對這些純文本內容做了任何改變，很快就會看到。

個人檔案

學歷

  • 國立成功大學醫學系學士

經歷

  • 2014年08月 ~迄今 胸腔內科醫師

指紋 查看啟用 Seu-Chun Yang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

  • 36 類似的檔案
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Quality of Life Medicine & Life Sciences
Life Expectancy Medicine & Life Sciences
Mutation Medicine & Life Sciences
Taiwan Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Cost-Benefit Analysis Medicine & Life Sciences

網絡 國家層面的近期外部合作。點選圓點深入探索詳細資料。

研究成果 2011 2019

  • 122 引文
  • 7 h-指數
  • 18 Article
  • 1 Comment/debate
  • 1 Editorial
1 引文 (Scopus)

Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up

Yang, S. C., Kuo, C. W., Lai, W. W., Lin, C. C., Su, W. C., Chang, S. M. & Wang, J. D., 2019 十一月, 於 : Journal of Thoracic Oncology. 14, 11, p. 1892-1900 9 p.

研究成果: Article

開啟存取
Lung Neoplasms
Health
Quality of Life
Drug Therapy
Therapeutics

Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: An interrupted time series study

Hsu, J. C., Wei, C. F. & Yang, S. C., 2019 三月 1, 於 : BMJ open. 9, 3, e022293.

研究成果: Article

開啟存取
Taiwan
Non-Small Cell Lung Carcinoma
Therapeutics
National Health Programs
Interrupted Time Series Analysis

Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

Su, P. L., Yang, S. C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W. Y., Tseng, Y. L., Lai, W. W., Ho, C. L., Lin, C. C. & Su, W. C., 2019 十月 1, 於 : Cancer medicine. 8, 13, p. 5939-5947 9 p.

研究成果: Article

開啟存取
DNA
Neoplasms
Mutation
Disease-Free Survival
Therapeutics

Diminishing marginal cost-effectiveness in risk-targeted lung cancer screening

Yang, S-C. & Wang, J-D., 2018 十月 1, 於 : Translational Cancer Research. 7, 5, p. 1310-1312 3 p.

研究成果: Editorial

Early Detection of Cancer
Cost-Benefit Analysis
Lung Neoplasms
5 引文 (Scopus)

Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer

Yang, S. C., Lin, C. C., Lai, W. W., Chang, S. M., Hwang, J. S., Su, W. C. & Wang, J. D., 2018 一月 1, 於 : Therapeutic Advances in Medical Oncology. 10

研究成果: Article

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Quality of Life
Mutation
Therapeutics